title: Should intralesional bleomycin be used in the treatment of human papillomavirus-related genital disease in the immunocompromised host?
authors.affiliation: Department of Dermatology, University of Illinois at Chicago, Chicago, Illinois. Electronic address: elianakrulig@yahoo.com.
authors.forename: Eliana
authors.initials: E
authors.lastname: Krulig
authors.affiliation: Department of Dermatology, University of Illinois at Chicago, Chicago, Illinois.
authors.forename: Sophie Marie
authors.initials: SM
authors.lastname: Worobec
mesh_terms: D052685:Alphapapillomavirus; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D030361:Papillomavirus Infections / Q000628:therapy*; D010412:Penile Neoplasms / Q000628:therapy*; D014625:Vaginal Neoplasms / Q000628:therapy*; D014846:Vulvar Neoplasms / Q000628:therapy*; D014860:Warts / Q000628:therapy*